Legionnaires’ Bacteria at GSK

GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after Legionella bacteria are detected in two external cooling towers.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Colorized scanning electron micrograph of Legionella pneumophila bacteriaWIKIMEDIA, CDCOn Tuesday (August 11), pharmaceutical giant GlaxoSmithKline (GSK) closed down a manufacturing plant in Zebulon, North Carolina, and sent employees home after the bacteria that cause Legionnaires’ disease were discovered in a cooling tower. The pathogen was subsequently found in a second cooling tower. But after concluding that the contamination posed no risk to its employees or products, the pharma company announced it would reopen by the weekend, after both towers have been cleaned.

“Given the location and level of bacteria found, this situation posed no risk to the products manufactured inside the building,” a GSK spokesperson told The Wall Street Journal yesterday (August 13). “We anticipate resuming production in the next 72 hours after cleaning, disinfecting, and returning the plant back to normal operating conditions.”

Separately, company spokesperson Jenni Ligday told FiercePharma that all drugs produced in the facility before the contamination was discovered are fine to use. “The cooling towers are external units with no contact with product or employees. Our products are safe and effective when used as prescribed.”

This marks the second widely reported discovery of Legionella in cooling towers this year. Since July, New York City health authorities have identified the bacterium in five ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide